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lowest-cost 2008 plan. When cost savings were calculated by
individual participant, this equated to a median annual OOP cost
savings of $98.00 (22.3%) per participant. CONCLUSION:
Trained student pharmacists can provide community-based inter-
ventions that reduce OOP prescription drug plan costs among
underserved Medicare populations.
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OBJECTIVE: Falls in the elderly pose signiﬁcant health risk with
substantial effects on health resource utilization and cost; 95% of
hip fractures are due to falls. Previous estimates of the costs of
falls used administrative data which underestimate falls inci-
dence. We aimed to estimate the direct health costs of injurious
falls requiring Emergency Department (ED) care. METHODS:
Information was collected on patients >70 years who presented
to the ED of Vancouver General Hospital. Fallers were identiﬁed
though a search of ED census, ED presenting complaints, ED
consultant records, and patient charts for reports of a fall. From
hospital reports, data were collected on patient demographics,
diagnoses, admission status, and hospital length of stay. Total
costs were estimated for each fall from the third payer perspec-
tive. Unit cost estimates for ED visits, and hospitalizations were
taken from a fully allocated hospital cost model. RESULTS:
Between December 1 2006 and March 31 2007, we identiﬁed
390 falls by 381 individuals costing $2,520,641. The mean age of
fallers was 83.6 years (SD:7.4); 69% were women. Fallers sus-
tained 183 (47%) fractures—these included 70 hip (39%) and
22 pelvic (12%) fractures. Other common diagnoses were
contusions/lacerations (n = 63, 16%), and syncope (n = 31, 8%).
134 (34%) falls resulted in hospital admission with an average
length of stay of 31.6 days (SD:41.59) and mean cost of $18,375
(SD:23601). Logistic regression analysis showed that compared
to those <80 years, those >80 years were more likely to be
hospitalized (OR:1.8, 95% CI:1.1–3.0). Women were more likely
than men to be hospitalized (OR = 1.5, 95% CI:0.9–2.4),
however this association was not statistically signiﬁcant. After
adjusting for age and sex, a diagnosis of “fracture” was the
strongest predictor of hospitalization (OR:15.5, 95% CI:8.2–
27.2). CONCLUSION: Among seniors, the signiﬁcant cost of fall
related hospital admissions warrants increased fall prevention
programs in this population.
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OBJECTIVE: Uterine ﬁbroids are the most common tumours in
women during their reproductive years, yet there is consider-
able paucity of data on treatments’ effectiveness and costs. We
developed a Markov model to compare currently available
treatments with a new Magnetic Resonance Guided Focused
Ultrasound Sound Surgery (MRgFUS). METHODS: Current
practice, comprising of uterine artery embolization (UAE),
myomectomy and hysterectomy, was compared with MRgFUS,
the least invasive procedure. A Markov model was used to
simulate the clinical outcomes, costs, age and quality-of-life
parameters to provide informed decisions on the part of pro-
viders, payers, and patients. The results were expressed as costs
per quality- adjusted-life-year (QALY) gained. The analysis was
conducted from the perspective of the National Health Service
(NHS) in the UK. All model parameters were based on the
most recent literature (post 1999). The effects of uncertainty in
the model’s parameters were explored using extensive determin-
istic and probabilistic sensitivity analysis. RESULTS: MRgFUS
is likely to be cost-effective. In the base scenario, it is dominant,
that is, has a lower cost and better outcomes than existing
treatments, although the QALY difference per woman is small.
MRgFUS remains cost effective (30, 000 per QALY gained)
when using alternative assumptions regarding current practice,
health utility, and the effectiveness of alternative treatments
(complication, recurrence, and procedural death rates). Mul-
tiple simulations show the range of outcomes that might be
expected in all aspects of practice with the result that MRgFUS
remains cost-effective in more than 86% of the simulations.
CONCLUSION: The results of this study support the introduc-
tion of MRgFUS as a treatment for uterine ﬁbroids. A treat-
ment strategy starting with MRgFUS is potentially more
effective and less costly than the current practice.
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OBJECTIVE: A woman’s health-related quality of life (HRQoL)
can be affected by her premenstrual symptoms. The study objec-
tive was to assess the association between HRQoL and score
differences on the Premenstrual Symptoms Impact Survey
(PMSIS), a six-item instrument for measuring impact of premen-
strual symptoms on a woman’s HRQoL. METHODS: Data were
collected on the PMSIS and SF-12 Health Survey from a panel of
representative U.S. women 18–45 years via Internet (N = 971).
PMSIS scores were used to identify women “at risk for PMDD.”
Items from the SF-12 were dichotomized and regressed onto the
standardized PMSIS scores with age as a covariate. Logistic
regression was used to derive odds ratios (OR) for experiencing
a particular outcome as a function of score differences between
“at risk for PMDD” and the population mean of the PMSIS.
RESULTS: The overall sample mean PMSIS score was 26.6 (on a
standardized scale of 0–100 from no impact to severe impact).
Higher PMSIS scores were signiﬁcantly associated with increased
risk of negative HRQL outcomes (p < 0.01). Women identiﬁed as
“at risk for PMDD” (PMSIS score  64) had 383% increased
risk of pain interfering with normal work; 320% increased risk
of doing work or activities less carefully than usual due to emo-
tional problems; 253% increased risk of feeling limited in work
or activities due to physical health or feeling they accomplished
less due to emotional problems; and 196% increased risk of
feeling downhearted and depressed, and feeling little or no
energy. CONCLUSION: There is a signiﬁcant association
between higher PMSIS scores (more severe impact due to pre-
menstrual symptoms) and diminished role functioning, physical
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